Demant has had a tough second quarter, which has impacted the hearing aid manufacturer’s results for the first half of 2022 to such a degree it had to downgrade its full year guidance on Tuesday.
However, it wasn’t all bad – Demant’s business dubbed Diagnostics delivered huge growth in H1, which also meant that these results beat analysts’ expectations.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
FDA fast-tracks Eli Lilly's obesity candidate
Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.
Jefferies spots weaknesses in GN
One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.
Bavarian initiates new arm of phase III Covid-19 vaccine trial
The first patient has already been dosed in the US, and the Danish vaccine maker is now expanding the study to include Denmark and Belgium.
Life science CEOs' paychecks decrease as markets decline
When the markets are down, everyone is in the same boat, in theory -- however, former Ambu CEO Lars Marcher warns boards against unduly rewarding CEOs by changing pre-existing share-based programs.
Fujifilm doubles bottom line in annual report
Despite a 12.5% cost increase compared to the preceding year, Fujifilm Diosynth Biotechnologies managed to increase its profit twofold in 2021/2022.
Drug Safety Associate 
Senior CMC & Device Project Manager 
Product specialist 
KLIFO is looking for QA Specialist/Senior QA Specialist, GCP and GVP for our Glostrup office 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Senior/lead consultant at Emendo Engineering 
Senior CMC Regulatory Manager 
CMC Writer 
Principal Scientist - Drug Metabolism & Pharmacokinetics 
Clinical Project Lead 
CTM / Junior CTM Biotech 
Lab Manager 
Scientist Radiochemistry 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Nordic Key Account Manager, Hollister & Dansac 
Chief Business Officer